Search Within

Samuel Aaron Funt

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (17)
  3. Editorial (1)
Groups
  1. Department of Medicine (42)
  2. Genitourinary Oncology Service (42)
  3. Human Oncology and Pathogenesis Program (42)
  4. Solid Tumor Oncology Division (42)
  5. Weinberg Fellows (42)
  6. Department of Pathology and Laboratory Medicine (41)

More Groups

People
  1. David Solit (40)
  2. Dean Bajorin (38)
  3. Gopakumar Iyer (35)
  4. Hikmat Al-Ahmadie (35)
  5. Jonathan Rosenberg (34)
  6. Min Yuen Teo (28)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (7)
  4. 2021 (5)
  5. 2020 (9)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Clinical Cancer Research (3)
  3. JCO Precision Oncology (3)
  4. European Urology (2)
  5. American Journal of Surgical Pathology (1)
  6. Bladder Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (4)
  3. Elsevier Science, Inc. (3)
  4. Nature Publishing Group (3)
  5. American Society for Clinical Investigation (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MSK-ACCESS for the detection of fibroblast growth factor receptor-3 (FGFR3) mutations in plasma cell-free (cf)DNA of metastatic urothelial carcinoma (mUC) patients (pts) pre- and on erdafitinib (erda) therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Al-Ahmadie, H.; Brannon, A. R.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial carcinoma
    Journal Article

    Teo, M. Y.; Mota, J. M.; Whiting, K. A.; Li, H. A.; Funt, S. A.; Lee, C. H.; Solit, D. B.; Al-Ahmadie, H.; Milowsky, M. I.; Balar, A. V.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
    Journal Article

    Taylor, J.; Donoghue, M. T. A.; Ho, C.; Petrova-Drus, K.; Al-Ahmadie, H. A.; Funt, S. A.; Zhang, Y.; Aypar, U.; Rao, P.; Chavan, S. S.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs
    Journal Article

    Cheng, M. L.; Donoghue, M. T. A.; Audenet, F.; Wong, N. C.; Pietzak, E. J.; Bielski, C. M.; Isharwal, S.; Iyer, G.; Funt, S.; Bagrodia, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of extreme responses to anti-PD1/PDL1 checkpoint inhibitors (CPI) in metastatic urothelial cancer (mUC)
    Meeting Abstract

    Teo, M. Y.; Whiting, K.; Mota, J. M.; Li, H.; Regazzi, A. M.; Solit, D. B.; Aggen, D. H.; Lee, C. H.; Funt, S. A.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma
    Meeting Abstract

    Walasek, A.; Almassi, N.; Teo, M. Y.; Funt, S.; Schultz, N.; Dalbagni, G.; Hu, W.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Microsatellite instability (MSI-H) in metastatic urothelial carcinoma (mUC): A biomarker of divergent responses to systemic therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Al-Ahmadie, H.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Solit, D. B.; Ratna, N.; Regazzi, A. M.; Hechtman, J. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Defining the genetic evolution of epigenetic alterations in bladder cancer
    Meeting Abstract

    Clinton, T. N.; Wise, H.; Almassi, N.; Chavan, S. S.; Hu, W.; Gao, S. P.; Hanrahan, A.; Dason, S.; Pietzak, E. J.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Cancer susceptibility mutations in patients with urothelial malignancies
    Journal Article

    Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) arising from teratoma in late relapse germ cell tumor (GCT)
    Meeting Abstract

    Wong, N. C.; Dason, S.; Dean, L. W.; Isharwal, S.; Donoghue, M.; Jia, L.; Joseph, G.; Tap, W. D.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save